Peptides researched for
Celiac disease / gluten barrier
1 peptide · 1 study
What people research this for
People with celiac disease have to avoid gluten completely, and even small slips can make them sick. Many hope for extra protection against accidental exposure. One peptide, larazotide, has been studied for that.
Researched for
- Celiac disease
- Accidental gluten exposure
- Gut lining health
What the studies say so far
Larazotide is designed to tighten the seals between cells in the gut lining so that fewer gluten fragments get through. Reviews describe this approach and the studies behind it. It is still experimental, and researchers study it as an add-on. A strict gluten-free diet remains the standard care.
Peptides studied
Each peptide below has been studied in this area. The label shows how far that research has gone.
Larazotide
Small early studies in peopleResearch review · 1 study
Study note. Larazotide acetate is reviewed as a tight-junction regulator for celiac disease, adjunct research, not a gluten-free-diet replacement.
- The potential utility of tight junction regulation in celiac disease: focus on larazotide acetate. (opens in a new tab)
Khaleghi S, Ju JM, Lamba A · Therapeutic advances in gastroenterology · 2016 · PubMed
- The potential utility of tight junction regulation in celiac disease: focus on larazotide acetate. (opens in a new tab)
Look this up in the PeptIQ app
The app has the same research and sources, next to the tools you use to track your own protocol.
Open in the PeptIQ app